{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:14:37Z","timestamp":1787062477069,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.transci.2014.12.027","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T14:11:50Z","timestamp":1421244710000},"page":"300-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Platelet-rich plasma as treatment for persistent ocular epithelial defects"],"prefix":"10.1016","volume":"52","author":[{"given":"Corrado","family":"Ronci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Salvatore","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Missiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sinopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Del Proposto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"De Felici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Arcese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Adorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2014.12.027_bib0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1537-2995.2004.03366.x","article-title":"The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study","volume":"44","author":"Mazzucco","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2014.12.027_bib0015","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0278-2391(97)90187-7","article-title":"Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery","volume":"55","author":"Whitman","year":"1997","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.transci.2014.12.027_bib0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.joms.2003.08.023","article-title":"Efficacy of platelet-rich plasma in alveolar bone grafting","volume":"62","author":"Oyama","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.transci.2014.12.027_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00001665-200401000-00006","article-title":"Repair of bony defect with combination biomaterials","volume":"15","author":"Velich","year":"2004","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.transci.2014.12.027_bib0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1302\/0301-620X.91B8.22546","article-title":"The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature","volume":"91","author":"Alsousou","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.transci.2014.12.027_bib0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/ten.teb.2008.0062","article-title":"The biology of platelet-rich plasma and its application in oral surgery: literature review","volume":"14","author":"Nikolidakis","year":"2008","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.transci.2014.12.027_bib0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1524-475X.2008.00443.x","article-title":"Tyrosine phosphorylation of EGR-R and PDGF-R proteins during acute cutaneous wound healing process in mice","volume":"17","author":"Gope","year":"2009","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.transci.2014.12.027_bib0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tmrv.2010.03.004","article-title":"Platelet-derived factors involved in tissue repair- from signal to function","volume":"24","author":"Mazzucco","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2014.12.027_bib0050","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1537-2995.2008.01862.x","article-title":"Quantitative assessment of the kinetics of growth factors release from platelet gel","volume":"48","author":"Su","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2014.12.027_bib0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1537-2995.2009.02439.x","article-title":"Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant","volume":"50","author":"Picardi","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2014.12.027_bib0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1423-0410.2007.01027.x","article-title":"Platelet-rich plasma and platelet gel preparation using Plateltex","volume":"94","author":"Mazzucco","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2014.12.027_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2014.12.027_bib0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1751-2824.2007.00085.x","article-title":"Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point?","volume":"2","author":"Borzini","year":"2007","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.transci.2014.12.027_bib0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/138920112800624373","article-title":"The role of leukocytes from L-PRP\/L-PRF in wound healing and immune defense: new perspectives","volume":"13","author":"Bielecki","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.transci.2014.12.027_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.22203\/eCM.v020a02","article-title":"A recently developed bifacial platelet-rich fibrin matrix","volume":"20","author":"Lucarelli","year":"2010","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.transci.2014.12.027_bib0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/138920112800624382","article-title":"Do the fibrin architecture and leukocyte content influence the growth factors release of platelet concentrates? An evidence based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte-and platelet-rich fibrin (L-PRF)","volume":"13","author":"Dohan Ehrenfest","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.transci.2014.12.027_bib0090","first-page":"107","article-title":"Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms","volume":"8","author":"Geremicca","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2014.12.027_bib0095","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1537-2995.2005.00600.x","article-title":"Tissue regeneration and in loco administration of platelet derivative: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms","volume":"45","author":"Borzini","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2014.12.027_bib0100","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1046\/j.1537-2995.2001.41101186.x","article-title":"Topical platelet growth factor therapy: of lotions and potions","volume":"41","author":"Snyder","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2014.12.027_bib0105","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2174\/138920112800624328","article-title":"In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes","volume":"13","author":"Dohan Ehrenfest","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.transci.2014.12.027_bib0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth factors and cytokines in wound healing","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.transci.2014.12.027_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1098\/rsif.2010.0223","article-title":"Growth factor delivery-based tissue engineering: general approaches and a review of recent developments","volume":"8","author":"Lee","year":"2011","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.transci.2014.12.027_bib0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.transci.2012.06.006","article-title":"\u201cReasonable compromise\u201d to define the quality standards of platelet concentrate for non-transfusion use (CPunT)","volume":"47","author":"Mazzucco","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2014.12.027_bib0125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/138920112800624355","article-title":"The role of \u201ceye platelet rich plasma\u201d (E-PRP) for wound healing in ophthalmology","volume":"13","author":"Ali\u00f2","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.transci.2014.12.027_bib0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000100933","article-title":"Symptomatic dry eye treatment with autologous platelet-rich plasma","volume":"39","author":"Alio","year":"2007","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.transci.2014.12.027_bib0135","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ophtha.2006.10.044","article-title":"Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers","volume":"114","author":"Alio","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2014.12.027_bib0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3928\/1081-597X-20070601-13","article-title":"Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma","volume":"23","author":"Alio","year":"2007","journal-title":"J Refract Surg"},{"key":"10.1016\/j.transci.2014.12.027_bib0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/ICO.0b013e31825a6d9a","article-title":"Bovine pericardium membrane (tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers","volume":"32","author":"Alio","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2014.12.027_bib0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamaophthalmol.2013.2474","article-title":"Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study","volume":"131","author":"Alio","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.transci.2014.12.027_bib0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e3181a81820","article-title":"Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects","volume":"29","author":"Lopez-Plandolit","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2014.12.027_bib0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effects of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2014.12.027_bib0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous serum application in the treatment of neurotriphic keratopathy","volume":"111","author":"Matsumoto","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2014.12.027_bib0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/bjo.83.4.399","article-title":"Amniotic membrane transplantation for ocular surface reconstruction","volume":"83","author":"Azuara-Blanco","year":"1999","journal-title":"Br J Opthalmol"},{"key":"10.1016\/j.transci.2014.12.027_bib0175","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","article-title":"Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratisis","volume":"114","author":"Yoon","year":"2007","journal-title":"Ophtalmology"},{"key":"10.1016\/j.transci.2014.12.027_bib0180","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ICO.0b013e3182114661","article-title":"Topical autologouis platelet-rich plasma eyedrops for acute corneal chemical injury","volume":"31","author":"Panda","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2014.12.027_bib0185","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(99)90444-X","article-title":"Multilayer amniotic menbrane transplantation for reconstruction of deep corneal ulcers","volume":"106","author":"Kruse","year":"1999","journal-title":"Ophtalmology"},{"key":"10.1016\/j.transci.2014.12.027_bib0190","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.biomaterials.2007.06.037","article-title":"The potential effects of the preparation rich in growth factors (PRGF) in different medical fields","volume":"28","author":"Anitua","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.transci.2014.12.027_bib0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","article-title":"Platelet-rich plasma: evidence to support its use","volume":"62","author":"Marx","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.transci.2014.12.027_bib0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00008505-200110000-00002","article-title":"Platelet-rich plasma (PRP): what is PRP and what is not PRP?","volume":"10","author":"Marx","year":"2001","journal-title":"Implant Dent"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050214002651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050214002651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T14:42:56Z","timestamp":1566225776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050214002651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1473050214002651"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2014.12.027","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-rich plasma as treatment for persistent ocular epithelial defects","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2014.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}